Capozide 50/15 and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Capozide 50/15 and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: captopril / hydrochlorothiazide
Brand name: Capozide 25/15, Capozide 25/25, Capozide 50/15, Capozide 50/25
Synonyms: Capozide 50/15 (Oral)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Capozide 50/15-Insulin glargine, recombinant Subcutaneous
- Capozide 50/15-Insulin glulisine
- Capozide 50/15-Insulin Glulisine (Cartridges and Pens)
- Capozide 50/15-Insulin Glulisine (Vials)
- Capozide 50/15-Insulin glulisine Subcutaneous
- Capozide 50/15-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Capozide 50/25
- Insulin glargine and lixisenatide Subcutaneous-Caprelsa
- Insulin glargine and lixisenatide Subcutaneous-Capreomycin
- Insulin glargine and lixisenatide Subcutaneous-Capreomycin Injection
- Insulin glargine and lixisenatide Subcutaneous-Capreomycin Sulfate
- Insulin glargine and lixisenatide Subcutaneous-Capron DM